BACKGROUND AND AIMS: The impact of diagnosis and treatment delays for non-small cell lung cancer management is poorly understood, even if the literature on the subject is currently increasing in importance. We have few indicators that can serve as reference for quality assurance actions. The objective of this review was to review the literature on the subject. METHODS: A literature search, using the words 'human lung cancer delay' and 'human lung cancer waiting time', was undertaken in Medline database. RESULTS: Several studies analyzed these delays mostly in a monocentric setting. There is an important variability in the definition of these delays, in the collection methods and in the results obtained. However, it seems distinctly clear that long delays are frequently observed in less symptomatic patients and, therefore, are accompanied by better prognosis. CONCLUSION: More standardized definitions and procedures to calculate time intervals between cancer diagnosis and treatment should be implemented to better understand the delays of lung cancer management.
BACKGROUND AND AIMS: The impact of diagnosis and treatment delays for non-small cell lung cancer management is poorly understood, even if the literature on the subject is currently increasing in importance. We have few indicators that can serve as reference for quality assurance actions. The objective of this review was to review the literature on the subject. METHODS: A literature search, using the words 'humanlung cancer delay' and 'humanlung cancer waiting time', was undertaken in Medline database. RESULTS: Several studies analyzed these delays mostly in a monocentric setting. There is an important variability in the definition of these delays, in the collection methods and in the results obtained. However, it seems distinctly clear that long delays are frequently observed in less symptomatic patients and, therefore, are accompanied by better prognosis. CONCLUSION: More standardized definitions and procedures to calculate time intervals between cancer diagnosis and treatment should be implemented to better understand the delays of lung cancer management.
Authors: Kimberley S Mak; Annelotte C M van Bommel; Caleb Stowell; Janet L Abrahm; Matthew Baker; Clarissa S Baldotto; David R Baldwin; Diana Borthwick; David P Carbone; Aileen B Chen; Jesme Fox; Tom Haswell; Marianna Koczywas; Benjamin D Kozower; Reza J Mehran; Franz M Schramel; Suresh Senan; Robert G Stirling; Jan P van Meerbeeck; Michel W J M Wouters; Michael D Peake Journal: Eur Respir J Date: 2016-07-07 Impact factor: 16.671
Authors: Usha Menon; Peter Vedsted; David Weller; Alina Zalounina Falborg; Henry Jensen; Samantha Harrison; Irene Reguilon; Andriana Barisic; Rebecca J Bergin; David H Brewster; John Butler; Odd Terje Brustugun; Oliver Bucher; Victoria Cairnduff; Anna Gavin; Eva Grunfeld; Elizabeth Harland; Jatinderpal Kalsi; Anne Kari Knudsen; Mats Lambe; Rebecca-Jane Law; Yulan Lin; Martin Malmberg; Donna Turner; Richard D Neal; Victoria White Journal: BMJ Open Date: 2019-11-27 Impact factor: 2.692
Authors: Momen M Wahidi; Samira Shojaee; Carla R Lamb; David Ost; Fabien Maldonado; George Eapen; Daniel A Caroff; Michael P Stevens; Daniel R Ouellette; Craig Lilly; Donna D Gardner; Kristen Glisinski; Kelly Pennington; Raed Alalawi Journal: Chest Date: 2020-05-01 Impact factor: 9.410
Authors: Virginia Leiro-Fernández; Cecilia Mouronte-Roibás; Esmeralda García-Rodríguez; Maribel Botana-Rial; Cristina Ramos-Hernández; María Torres-Durán; Alberto Ruano-Raviña; Alberto Fernández-Villar Journal: Thorac Cancer Date: 2019-01-03 Impact factor: 3.500